Exploiting the potential of vaccines and GGSK- 1/30 mAb based ADC against MUC1 for immunotherapy of adenocarcinomas
Loading...
Date issued
Authors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Reuse License
Description of rights: InC-1.0